| Primary |
| Chronic Obstructive Pulmonary Disease |
50.0% |
| Rhinitis Allergic |
50.0% |
|
| Haemoptysis |
20.0% |
| Nocturnal Dyspnoea |
20.0% |
| Rash |
20.0% |
| Substance-induced Psychotic Disorder |
20.0% |
| Tachycardia |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
78.5% |
| Chronic Obstructive Pulmonary Disease |
12.7% |
| Lung Infection |
3.8% |
| Hypertension |
2.5% |
| Arthralgia |
1.3% |
| Primary Ciliary Dyskinesia |
1.3% |
|
| Wheezing |
33.3% |
| Abdominal Discomfort |
16.7% |
| Stress Cardiomyopathy |
16.7% |
| Tachycardia |
16.7% |
| Vital Capacity Decreased |
16.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
53.5% |
| Pain |
5.3% |
| Asthma |
5.2% |
| Hypertension |
3.5% |
| Diffuse Large B-cell Lymphoma |
3.3% |
| Diabetes Mellitus |
3.1% |
| Hiv Infection |
2.8% |
| Chronic Obstructive Pulmonary Disease |
2.7% |
| Hypersensitivity |
2.1% |
| Cardiac Failure Congestive |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Ill-defined Disorder |
1.9% |
| Nasal Congestion |
1.9% |
| Peyronie's Disease |
1.8% |
| Anxiety |
1.4% |
| Bipolar Disorder |
1.4% |
| Constipation |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Cough |
1.3% |
|
| Vision Blurred |
10.3% |
| Wheezing |
10.3% |
| White Blood Cell Count Decreased |
9.0% |
| Pruritus |
6.4% |
| Eczema |
5.1% |
| Malaise |
5.1% |
| Pulmonary Embolism |
5.1% |
| Squamous Cell Carcinoma |
5.1% |
| Syncope |
5.1% |
| Tachycardia |
5.1% |
| Toxicity To Various Agents |
5.1% |
| Liver Function Test Abnormal |
3.8% |
| Pneumonia |
3.8% |
| Renal Failure Chronic |
3.8% |
| Sputum Abnormal |
3.8% |
| Blood Cholesterol Increased |
2.6% |
| Cardiac Failure Chronic |
2.6% |
| Deep Vein Thrombosis |
2.6% |
| Enteritis |
2.6% |
| Grand Mal Convulsion |
2.6% |
|
